Literature DB >> 31744661

Controlling Immunity and Inflammation through Integrin-Dependent Regulation of TGF-β.

Martijn Nolte1, Coert Margadant2.   

Abstract

Integrins promote cell adhesion and migration, but also control local activation of latent transforming growth factor (TGF)-β contained in extracellular matrix or cell-surface reservoirs. Integrin-dependent activation of TGF-β has emerged as a crucial mechanism whereby tissue-borne cells instruct circulating and resident immune cells. Moreover, this regulation has wide pathophysiological implications in wound healing, tissue fibrosis, antibody production, pathogen clearance, inflammation, autoimmunity, cancer, and possibly metabolic disorders including diabetes. Here we review the spatiotemporal control of TGF-β activation by integrins, and its effects on immune cell signaling and function. We discuss the underlying molecular and cell-biological mechanisms, the implications for human health and disease, and possibilities for future therapeutic exploitation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  TGF-β activation; immunity; immunotherapy; inflammation; integrins; metabolism; regulatory T cells

Mesh:

Substances:

Year:  2019        PMID: 31744661     DOI: 10.1016/j.tcb.2019.10.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  21 in total

Review 1.  Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis.

Authors:  Alexandra Desnoyers; Carlos González; Pedro Pérez-Segura; Atanasio Pandiella; Eitan Amir; Alberto Ocaña
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

Review 2.  Overcoming TGFβ-mediated immune evasion in cancer.

Authors:  Daniele V F Tauriello; Elena Sancho; Eduard Batlle
Journal:  Nat Rev Cancer       Date:  2021-10-20       Impact factor: 60.716

3.  HAPLN1 Affects Cell Viability and Promotes the Pro-Inflammatory Phenotype of Fibroblast-Like Synoviocytes.

Authors:  Yong Chen; Baojiang Wang; Yanjuan Chen; Qunyan Wu; Wing-Fu Lai; Laiyou Wei; Kutty Selva Nandakumar; Dongzhou Liu
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

4.  USP1-WDR48 deubiquitinase complex enhances TGF-β induced epithelial-mesenchymal transition of TNBC cells via stabilizing TAK1.

Authors:  Dianwen Han; Lijuan Wang; Bing Chen; Wenjing Zhao; Yiran Liang; Yaming Li; Hanwen Zhang; Ying Liu; Xiaolong Wang; Tong Chen; Chen Li; Xiaojin Song; Dan Luo; Zheng Li; Qifeng Yang
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

Review 5.  TGF-β: Many Paths to CD103+ CD8 T Cell Residency.

Authors:  Zhijuan Qiu; Timothy H Chu; Brian S Sheridan
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

6.  Integrin signaling gene alterations and outcomes of cancer patients receiving immune checkpoint inhibitors.

Authors:  Panagiotis J Vlachostergios
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

7.  SU16f inhibits fibrotic scar formation and facilitates axon regeneration and locomotor function recovery after spinal cord injury by blocking the PDGFRβ pathway.

Authors:  Ziyu Li; Shuisheng Yu; Yanchang Liu; Xuyang Hu; Yiteng Li; Zhaoming Xiao; Yihao Chen; Dasheng Tian; Xinzhong Xu; Li Cheng; Meige Zheng; Juehua Jing
Journal:  J Neuroinflammation       Date:  2022-04-16       Impact factor: 9.587

Review 8.  Targeting TGFβ signal transduction for cancer therapy.

Authors:  Sijia Liu; Jiang Ren; Peter Ten Dijke
Journal:  Signal Transduct Target Ther       Date:  2021-01-08

Review 9.  Noise-Induced Hearing Loss: Updates on Molecular Targets and Potential Interventions.

Authors:  Huanyu Mao; Yan Chen
Journal:  Neural Plast       Date:  2021-07-06       Impact factor: 3.599

10.  Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a.

Authors:  Yang Wu; Zongjing Fan; Zhengju Chen; Jiqiang Hu; Jie Cui; Yang Liu; Yao Wang; Bin Guo; Juan Shen; Liandi Xie
Journal:  Mol Cell Biochem       Date:  2020-05-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.